المؤلفون: Kang EH; Division of Rheumatology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Shin A; Division of Rheumatology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Park CS; Division of Rheumatology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Lee EB; Division of Rheumatology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea., Lee YJ; Division of Rheumatology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Curhan G; Channing Division of Network Medicine and Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Choi HK; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Sep 01; Vol. 63 (9), pp. 2433-2441.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Benzbromarone*/therapeutic use , Benzbromarone*/adverse effects , Allopurinol*/therapeutic use , Allopurinol*/adverse effects , Gout*/drug therapy , Urolithiasis*/chemically induced , Urolithiasis*/epidemiology , Gout Suppressants*/therapeutic use , Gout Suppressants*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Republic of Korea/epidemiology ; Uricosuric Agents/therapeutic use ; Cohort Studies ; Incidence ; Proportional Hazards Models ; Risk Factors ; Adult

المؤلفون: Chen W; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Jiang B; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Ruan Z; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Yang D; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Hu Y; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Lou H; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. louhg@zju.edu.cn.

المصدر: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2024 Aug 26; Vol. 25 (1), pp. 57. Date of Electronic Publication: 2024 Aug 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Fasting* , Febuxostat*/pharmacokinetics , Febuxostat*/blood , Food-Drug Interactions* , Gout Suppressants*/pharmacokinetics , Gout Suppressants*/blood , Gout Suppressants*/administration & dosage , Models, Biological*, Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Biological Availability ; Cross-Over Studies ; Therapeutic Equivalency ; White People ; East Asian People

المؤلفون: Stamp L; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand Lisa.Stamp@cdhb.health.nz., Te Karu L; Department of General Practice and Primary Health Care, University of Auckland, Auckland, Aotearoa New Zealand., Reid S; Health Literacy NZ, Auckland, New Zealand., Wright DFB; School of Pharmacy, University of Sydney, Sydney, New South Wales, Australia., Frampton C; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand., Tuitaupe VS; Nil, Christchurch, New Zealand., Dalbeth N; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

المصدر: BMJ open [BMJ Open] 2024 Aug 03; Vol. 14 (8), pp. e084665. Date of Electronic Publication: 2024 Aug 03.

نوع المنشور: Journal Article; Clinical Trial Protocol

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Allopurinol*/administration & dosage , Allopurinol*/therapeutic use , Gout*/drug therapy , Gout*/blood , Gout Suppressants*/administration & dosage , Gout Suppressants*/therapeutic use , Uric Acid*/blood, Humans ; New Zealand ; Male ; Dose-Response Relationship, Drug ; Adult ; Equivalence Trials as Topic ; Female

المؤلفون: Wilson LC; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Ward J; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Wright DFB; School of Pharmacy, University of Otago, Dunedin, New Zealand.; Sydney Pharmacy School, University of Sydney, Sydney, New South Wales, Australia., Green SC; Department of Medicine, University of Otago, Christchurch, New Zealand., Stocker SL; Sydney Pharmacy School, University of Sydney, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.; Sydney Musculoskeletal Health, Univ. of Sydney, Sydney, New South Wales, Australia., Putt TL; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Schollum JBW; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Walker RJ; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand.

المصدر: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Aug; Vol. 29 (8), pp. 547-550. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE

مواضيع طبية MeSH: Uric Acid*/blood , Gout*/drug therapy , Gout*/blood , Peritoneal Dialysis* , Oxypurinol*/pharmacokinetics , Gout Suppressants*/pharmacokinetics , Gout Suppressants*/therapeutic use, Humans ; Male ; Middle Aged ; Female ; Aged ; Allopurinol/therapeutic use ; Allopurinol/pharmacokinetics ; Renal Elimination ; Half-Life ; Dialysis Solutions/pharmacokinetics

المؤلفون: Suhas S; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India., Das D; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India., Kumar CN; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.; Corresponding Author: Channaveerachari N. Kumar, MD, DPM, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Rd, Bengaluru 560029, India (cnkumar1974@gmail.com).

المصدر: The primary care companion for CNS disorders [Prim Care Companion CNS Disord] 2024 Aug 01; Vol. 26 (4). Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Case Reports; Letter; Journal Article

بيانات الدورية: Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 101547532 Publication Model: Electronic Cited Medium: Internet ISSN: 2155-7780 (Electronic) Linking ISSN: 21557780 NLM ISO Abbreviation: Prim Care Companion CNS Disord Subsets: MEDLINE

مواضيع طبية MeSH: Allopurinol*/therapeutic use , Allopurinol*/administration & dosage , Gout*/drug therapy , Gout*/complications , Gout Suppressants*/administration & dosage , Gout Suppressants*/therapeutic use, Humans ; Male ; Mania/drug therapy ; Bipolar Disorder/drug therapy ; Bipolar Disorder/complications ; Middle Aged

المؤلفون: Li C; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Wang Y; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China., Mu R; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Zhao J; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Yao Z; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Zhai J; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Jin Y; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Liu R; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Liu D; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China., Hong K; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China., Jiang H; Department of Urology, Peking University First Hospital, Beijing, 100034, China. jianghui@bjmu.edu.cn.; Institute of Urology, Peking University, Beijing, 100034, China. jianghui@bjmu.edu.cn., Zhang Z; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China. zhezhang@bjmu.edu.cn.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China. zhezhang@bjmu.edu.cn.

المصدر: Rheumatology international [Rheumatol Int] 2024 Jul; Vol. 44 (7), pp. 1245-1253. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-160X (Electronic) Linking ISSN: 01728172 NLM ISO Abbreviation: Rheumatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Allopurinol*/therapeutic use , Benzbromarone*/therapeutic use , Febuxostat*/therapeutic use , Febuxostat*/pharmacology , Gout*/drug therapy , Gout*/blood , Gout Suppressants*/therapeutic use , Gout Suppressants*/adverse effects , Spermatozoa*/drug effects, Adolescent ; Adult ; Humans ; Male ; Middle Aged ; Young Adult ; Prospective Studies ; Semen Analysis ; Sperm Count ; Sperm Motility/drug effects ; Uric Acid/blood

المؤلفون: Gilmore S; The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA., Carroll M; The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA., Koselke E; The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA., Hough S; The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 867-872. Date of Electronic Publication: 2023 Aug 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Lysis Syndrome*/drug therapy , Urate Oxidase*/administration & dosage , Urate Oxidase*/therapeutic use , Hyperuricemia*/drug therapy , Gout Suppressants*/administration & dosage , Gout Suppressants*/therapeutic use, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Practice Guidelines as Topic ; Dose-Response Relationship, Drug ; Adult

المؤلفون: da Rocha Castelar Pinheiro G; Serviço de Reumatologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. geraldo.castelar@gmail.com.; Sociedade Brasileira de Reumatologia, São Paulo, Brazil. geraldo.castelar@gmail.com.; Rheumatology Discipline, Pedro Ernesto University Hospital, Blvd. 28 de Setembro 77 Vila Isabel, Rio de Janeiro, RJ, 20551-0301, Brazil. geraldo.castelar@gmail.com., da Rocha Loures MAA; Sociedade Brasileira de Reumatologia, São Paulo, Brazil.; Departamento de Medicina, Universidade Estadual de Maringá, Maringá, Paraná, Brazil., Andrade LEC; Sociedade Brasileira de Reumatologia, São Paulo, Brazil.; Departamento de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil., de Almeida Brito F; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil., de Souza Vasconcellos L; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil.

المصدر: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Sep 26; Vol. 64 (1), pp. 73. Date of Electronic Publication: 2024 Sep 26.

نوع المنشور: Journal Article; Practice Guideline; Letter

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106 (Electronic) Linking ISSN: 25233106 NLM ISO Abbreviation: Adv Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/blood , Gout*/drug therapy , Uric Acid*/blood , Gout Suppressants*/therapeutic use, Humans ; Brazil ; Societies, Medical ; Rheumatology

المؤلفون: Schulz M; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia., Day RO; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia. r.day@unsw.edu.au.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Victoria Street, Darlinghurst, NSW, 2010, Australia. r.day@unsw.edu.au., Coleshill MJ; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Victoria Street, Darlinghurst, NSW, 2010, Australia.; Black Dog Institute, Sydney, NSW, Australia., Briggs NE; Stats Central, Mark Wainwright Analytical Centre, UNSW, Sydney, Australia., Aung E; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia.; Northern Sydney Local Health District, NSW Health, Sydney, NSW, Australia.; Kolling Institute, Pain Management Research Institute, The University of Sydney, Sydney, NSW, Australia.

المصدر: Clinical rheumatology [Clin Rheumatol] 2024 Sep; Vol. 43 (9), pp. 2943-2954. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/drug therapy , Medication Adherence*/statistics & numerical data , Psychometrics* , Gout Suppressants*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Australia ; Adult ; Surveys and Questionnaires ; Uric Acid/blood ; Factor Analysis, Statistical ; Reproducibility of Results ; Logistic Models ; Australasian People

المؤلفون: Steelandt A; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France., Hittinger A; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France. ahittinger-roux@chu-reims.fr., Kanagaratnam L; Methodological Support Unit, Research and Public Health Department, University Hospital of Reims, Reims, France., Kazes I; Nephrology Department, University Hospital of Reims, Reims, France., Clavel P; Local Association for Home Dialysis Promotion (ARPDD), Hemodialysis Unit, Reims, France., Bolko L; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France., Rieu P; Nephrology Department, University Hospital of Reims, Reims, France., Salmon JH; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France.

المصدر: BMC nephrology [BMC Nephrol] 2024 Aug 20; Vol. 25 (1), pp. 266. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Gout*/drug therapy , Gout*/blood , Renal Dialysis* , Gout Suppressants*/therapeutic use , Symptom Flare Up* , Uric Acid*/blood, Humans ; Male ; Retrospective Studies ; Female ; Aged ; Middle Aged ; Febuxostat/therapeutic use ; Allopurinol/therapeutic use ; Cohort Studies